Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
April 11, 2019
NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board
April 8, 2019
Audentes Therapeutics Announces Expansion of AAV Technology Platform and Pipeline with New Development Programs for Duchenne Muscular Dystrophy and Mytonic Dystrophy
April 4, 2019
Homology Medicines Presents Preclinical Data From PKU Gene Therapy Program Demonstrating Restored Metabolic Pathway And Increased Neurotransmitter Production
April 4, 2019
Homology Medicines Announces FDA Clearance of Investigational New Drug Application for HMI-102 Gene Therapy Candidate for PKU
April 3, 2019
RareCyte Expands Liquid Biopsy Offerings With The RarePlex™ CTC Developer Kit For Custom Biomarkers, And Introduces The Next Generation CytePicker® Cell Retrieval Module For Single Cell And Tissue Micro-Region Retrieval
April 3, 2019
Results From Combination of APR-246 with Immuno-Oncology Agents Presented at the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta
April 3, 2019
Cabaletta Bio Appoints Distinguished Immunotherapist and Cell Therapy Expert, Catherine Bollard, M.D., to its Board of Directors
March 25, 2019
Arvinas Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of PROTAC™ Protein Degrader, ARV-110
March 11, 2019
RareCyte Expands Liquid Biopsy Offerings With The RarePlex™ CTC Developer Kit For Custom Biomarkers, And Introduces The Next Generation CytePicker® Cell Retrieval Module for Single Cell and Tissue Micro-Region Retrieval
February 27, 2019
Aprea Therapeutics Adds New Investor to Series C Financing
« Previous Page
1
…
8
9
10
11
12
Next Page »